Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal

5 trials 4 recruiting Academic / non-commercial

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

1 Completed trials

2 Countries active

7 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 3 Phase IV: 1

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Bronchopulmonary dysplasia 1 Myopia 1 HIV infection 1

Top IMPs

BRIMONIDINE TARTRATE 1 DOLUTEGRAVIR SODIUM 1 LAMIVUDINE 1 MARAVIROC 1 MESENCHYMAL CELLS 1 REZAFUNGIN ACETATE 1

All trials

5 total

Brimonidine eye drops in the prevention of myopia progression Recruiting

2025-521878-33-00 Phase II 1 country BRIMONIDINE TARTRATE
Phase II, multicenter, open-label, randomized, controlled, open-label clinical trial to eliminate the latent reservoir of HIV-1 by administr… Recruiting

2024-513366-18-00 Phase II 1 country DOLUTEGRAVIR SODIUM; LAMIVUDINE; MARAVIROC
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism Recruiting

2024-511959-18-01 Phase III 2 countries
PHASE II CLINICAL TRIAL TO ESTABLISH THE SAFETY OF THE USE OF EXPANDED ALLOGENEIC FETAL UMBILICAL CORD STEM MESENCHYMAL CELLS IN PRETERM PAT… Recruiting

2024-516677-79-00 Phase II 1 country MESENCHYMAL CELLS
Pharmacokinetic Study of Rezafungin in Patients with Suspected Intra-Abdominal Candidiasis: Peritoneal Diffusion and Candicidal Activity Ended

2025-521854-40-00 Phase IV 1 country REZAFUNGIN ACETATE

Showing 1–5 of 5 trials

← All sponsors A–Z